Form 4: MicroVision Executive Vice Chair Converts RSUs
Insider Transaction Report
Simon Biddiscombe, Executive Vice Chair of MicroVision, acquired 22,007 shares of common stock through the vesting of restricted stock units.
Summary
- Simon Biddiscombe, Executive Vice Chair and Director of MicroVision, Inc. (MVIS), acquired 22,007 shares of common stock on December 1, 2025.
- The acquisition resulted from the vesting of restricted stock units (RSUs) which converted into common stock on a unit-for-share basis without payment.
- Following this transaction, Biddiscombe directly beneficially owns 269,292 shares of MicroVision common stock.
- The RSUs were originally granted on June 6, 2025, and are scheduled to vest in four equal quarterly installments.
- A previous Form 4 filed on June 6, 2025, incorrectly reported the total RSUs granted on June 5, 2025, as 87,462 RSUs; the correct amount was 88,028 RSUs, and the current vesting is based on this corrected figure.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction (vesting of RSUs) and does not contain information that would significantly alter the company's financial or strategic outlook, thus maintaining a neutral sentiment.
Positives
- The vesting of restricted stock units increases the direct beneficial ownership of common stock by a key executive, Simon Biddiscombe, aligning his interests further with shareholders.
Future Outlook
The remaining unvested Restricted Stock Units are scheduled to continue vesting in equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on continued service as a director.
Industry Context
This filing represents a routine insider compensation event, common across publicly traded companies where executive compensation packages include equity awards like Restricted Stock Units to incentivize long-term performance and align management interests with shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reporting Correction | A previous Form 4 filed on June 6, 2025, incorrectly reported the total RSUs granted on June 5, 2025, as 87,462 RSUs. The correct amount was 88,028 RSUs, and the current vesting calculation is based on this corrected figure. | 06/05/2025 | This correction ensures accurate disclosure of executive equity compensation, reflecting a commitment to transparent financial reporting. |
Stakeholder Impact
- Shareholders: Increased alignment of executive interests with shareholder value through direct stock ownership.
- Employees: Standard compensation practices for executives, potentially influencing broader compensation strategies.
Next Steps
- Future vesting events for the remaining Restricted Stock Units will occur in equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders.
Key Dates
| Date | Description |
|---|---|
| 06/06/2025 | Original grant date of the Restricted Stock Units (RSUs). |
| 12/01/2025 | Date of transaction where 22,007 Restricted Stock Units vested and converted into common stock. |
| 12/02/2025 | Date the Form 4 filing was signed by the attorney-in-fact for Simon Biddiscombe. |
Keywords
MVIS, MicroVision, Form 4, Insider Transaction, RSU Vesting, Simon Biddiscombe, Executive Compensation, Stock Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.